Dupilumab and House Dust Mite Immunotherapy in Patients With Atopic Dermatitis

NCT06509243 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

132

Enrollment

OTHER

Sponsor class

Conditions

Atopic Dermatitis

Interventions

BIOLOGICAL: tablets Acarizax
BIOLOGICAL: dupilumab
DRUG: cyclosporine

Sponsor

Medical University of Silesia